PHIGENIXPRECISION. PURPOSE. POSSIBILITY.
MOLECULAR INSIGHT. HUMAN IMPACT.
Better science.
New possibilities
in cancer care.
Exploring the biology of cancer to advance a more personal approach to diagnosis and treatment.
Explore our science ↗THE PHIGENIX PURPOSE
Cancer is complex.
Our focus is precise.
Every advance begins with a better question. At PHIGENIX, we investigate molecular signals that may help reveal how cancers develop—and how they might be targeted.
Our research brings together diagnostic discovery, targeted therapeutics and the biology of tumor immunity.
Discover our approach ↗CONNECTED BY SCIENCE
From molecular signals
to new research directions.
Investigating PAX2, EN2 and human beta defensin-1 to explore new possibilities in personalized oncology.
Inside our platform ↗INSIGHT
OUR RESEARCH FOCUS
Three paths. One purpose.
New approaches to understanding and targeting cancer.
Companion
diagnostics
Studying biomarkers that may help identify which patients are more likely to respond to specific therapies.
Explore diagnostics ↗Targeted
therapeutics
Investigating cancer-associated molecular targets, including PAX2, with a focus on breast and prostate cancer.
Explore therapeutics ↗Tumor
immunity
Exploring human beta defensin-1 and investigational mRNA approaches in cancer research.
Explore tumor immunity ↗
SCIENTIST. INVENTOR. FOUNDER.
A vision grounded
in discovery.
Meet Dr. Carlton D. Donald, the molecular biologist and research scientist who founded PHIGENIX in 2007.
Meet our founder ↗ADVANCING TOGETHER